“…Although sen- 1-18, 20-27 1, 2, 5, 7, 9, 12-16, 18, 20-23, 26, 27 1-3, 5, 7, 9, 11, 15, 16, 22, 24, 26, 27 5, 6, 11, 12, 14, 17, 19, 27 5, 11 4, 5, 7, 10-12, 14, 18-20, 22, 24-27 7, 9, 14, 24 2, 15, 16, 20 9, 17, 25, 26 Morrow & Creese, 1986;(3) Honda et al, 1987;(4) Gross et al, 1988;(5) Boer et al, 1989;(6) Hanft & Gross, 1989a; (7) Hanft & Gross, 1989b;(8) Hanft et al, 1989;(9) Michel et al, 1989;(10) (11) Michel et al, 1990;(12) Eltze et al, 1991;(13) Feng et al, 1991;(14) Klijn et al, 1991;(15) Oshita et al, 1991;Tsuchihashi et al, 1991;(17) Eltze & Boer, 1992;(18) Hiramatsu et al, 1992;(19) Jackson et al, 1992;(20) Muramatsu, 1992;(21) Ohmura et al, 1992;(22) Yazawa et al, 1992;(23) Ivorra et al, 1993;(24) Michel et al, 1993a;(25) Schwietert et al, 1993;(26) Sleight et al, 1993;(27) Kidney (pKB or pA2) Figure 8 Correlations of antagonist affinity estimates (pA2 values) at az-adrenoceptors in isolated perfused kidney of rat and antagonist affinity estimates (pK, values) in cloned (a) MIB-adrenoceptors, (b) otc-adrenoceptors and (c) alD-adrenoceptors: (1) sitivity to nitrendipine does not provide insight into the identity of the receptor, it is nevertheless an important finding as it allows pharmacological 'isolation' of the cladrenoceptor at which 5-methyl-urapidil exerts high affinity and, therefore, characterization and classification of the site. For this reason, agonists and antagonists (tested subsequently to using 5-methyl-urapidil) were studied in the presence of nitrendipine (see Table 1).…”